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Case Report
Optic Neuropathy Associated with Castleman Disease
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A 44-year-old woman with Castleman disease presented with acute visual loss in the left eye. A full ophthalmologic 
examination and imaging were performed. Visual acuity was 20/20 in the right eye and 20/100 in the left eye. Total 
dyschromatopsia, a relative afferent pupillary defect, and a cecocentral scotoma were observed in the left eye. Mild 
disc edema, without leaking during fluorescein angiography, was also observed. Magnetic resonance imaging re-
vealed a small cystic epidermoid-like lesion in the right prepontine and suprasellar cistern. Her visual acuity did not 
improve and deteriorated to 20/200 in the left eye at 22 months after the initial visual loss. Optic neuropathy may 
rarely be associated with Castleman disease and suggests a poor prognosis. 
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Castleman disease (CD) was first described by Dr. Benjamin 
Castleman and is a rare lymphoproliferative disorder of un-
known etiology with different clinical manifestations such as 
fever, night sweats, malaise, and weight loss [1]. CD is clas-
sified into a hyaline vascular variant and plasma cell variant 
(unicentric and multicentric) [2]. Although several nonlymphoid 
organs can be involved, ocular findings are very rare. Only 
cases of serous retinal detachment, thickening of the sclera, 
involvement of the lacrimal glands, and papilledema asso-
ciated with an intracranial leptomeningeal mass have been 
reported [3,4]. An association with optic neuropathy has not 
been reported to date.
Case Report
A 44-year-old woman presented with a 3 day history of 
acute visual loss in the left eye. She did not complain of ocu-
lar pain, but she did report a headache localized to the left 
side beginning one week prior. Two years prior she had suf-
fered from multicentric CD confirmed by histopathologic ex-
amination of a cervical lymph node. Rituximab was ad-
ministered and chemotherapy was performed with cyclo-
phosphamide, vincristine, doxorubicin, and prednisone. She 
did not have any other medical history including diabetes 
mellitus, hypertension, tuberculosis, or hyperlipidemia. She 
had never smoked and rarely drank alcohol. She had been 
suffering from myalgia and neuropathy at the onset of the optic 
neuropathy.
Ophthalmologic examination revealed a best-corrected 
visual acuity (BCVA) of 20/20 in the right eye and 20/100 in 
the left eye. A relative afferent pupillary defect was detected 
in the left eye. Color testing revealed total dyschromatopsia 
in the left eye. A cecocentral scotoma and inferonasal visual 
field defect was identified in the left eye (Fig. 1A). Mild disc 
edema was observed and fluorescein angiography showed 
mild disc edema without leakage; disc filling time was not 
delayed (Fig. 1C and 1D). Pattern visual evoked potentials 
showed a decreased amplitude and delayed latency in the left 
eye. The mutation for Leber’s hereditary optic neuropathy 
was not detected. Brain magnetic resonance imaging re-
vealed a small cystic lesion in the right prepontine and supra-
sellar cistern, which was suspicious for epidermoid (Fig. 2). 
The cystic lesion was not associated with the visual pathway, 
including the optic nerve. 
The patient refused to undergo steroid pulse therapy be-
cause she had experienced increased blood glucose levels 
and generalized edema during previous steroid pulse therapy 
for CD. Two weeks later her BCVA had decreased to hand 
motion and her visual field demonstrated a superotemporal 
field defect with a cecocentral scotoma. One month later her 
BCVA had improved to 20/100 and her color vision had im-US Kim and JM Hwang. Optic Neuropathy in Castleman Disease
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Fig.1. (A) Goldmann visual field examination showed a cecocentral scotoma and inferonasal visual field defect one day after the onset of visual 
loss. (B) The visual field defect improved to a central scotoma 40 days after the onset of visual loss. (C) Mild disc swelling was observed on 
fundus photography. (D) Fluorescein angiography demonstrated mild disc edema without leakage.
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Fig. 2. Magnetic resonance imaging revealed an epi-
dermoid-like mass in the right prepontine and supra-
sella cistern (arrow). (A,B) T2-weighted images. 
(C) Gadolinium enhanced T2-weighted image. (D) 
T1-weighted sagittal image.Korean J Ophthalmol Vol.24, No.4, 2010
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Fig. 3. Twenty-two months later, optical coherence tomography showed a diffuse decrease in retinal nerve fiber layer thickness 
in the left eye. TEMP=temporal; SUP=superior; NAS=nasal; INF=inferior; Imax=inferior maximum; Smax=superior 
maximum; Navg=nasal average; Savg=superior average; Tavg=temporal average; Iavg=inferior average.
proved to 2 out of 14 plates in the Ishihara color test. The 
visual field defect also improved to reveal only a central 
scotoma (Fig. 1B). At final follow-up 22 months later, her 
BCVA was stable at 20/200 and retinal nerve fiber loss was 
observed in 4 quadrants in the left eye with Stratus optical 
coherence tomography (Carl Zeiss Meditec, Dublin, CA, 
USA) (Fig. 3). 
Discussion
The patient presented herein was slightly younger than the 
ordinary age for anterior ischemic optic neuropathy (AION), 
had no AION risk factors such as hypertension, diabetes mel-
litus, smoking, or hyperlipidemia, and had no disc hemorrhage. 
However, she did demonstrate a cecocentral scotoma and to-
tal dyschromatopsia. In addition, disc filling time was not 
delayed during fluorescein angiography. Therefore, this 
case may be more compatible with optic neuritis compared 
to AION. The patient did not meet diagnostic criteria for pe-
ripheral neuropathy, organomegaly, endocrinopathy, a mon-
oclonal plasma cell disorder, and skin changes syndrome 
because she did not demonstrate monoclonality on repetitive 
urine protein electrophoresis. 
The mechanism behind the association of CD with optic 
neuropathy is unclear. CD is related to the overproduction of 
interleukin-6 and hyper-responsiveness to interleukin-6, 
which is often significantly increased in the serum of pa-
tients with optic neuritis [5-7]. Profound immunodeficiency US Kim and JM Hwang. Optic Neuropathy in Castleman Disease
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in multicentric CD resulting from apoptosis of T-cells or im-
munosuppression caused by chemotherapy or the long-term 
use of steroids may also cause an increased frequency of in-
fection [8]. Finally, we might speculate that the association 
between multicentric CD and the infection of Kaposi’s sar-
coma-associated herpes virus may be relevant to the devel-
opment of a neuropathy [9]. Altered immunity may be re-
sponsible for the development of neuromyelitis optica and 
CD [10]. 
In the present case, the patient's final visual acuity was 
very poor at 20/200. This is in contrast to the usual good visu-
al outcome of optic neuritis [11]. It is not clear whether a 
more aggressive treatment, such as steroid pulse therapy, 
would have improved the visual outcome in this case. Our 
case is the first report to suggest an association of CD with 
optic neuropathy; further cases can hopefully be identified 
and used to clarify this association. 
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